T2 Biosystems Expands Commercial Presence with New Distribution Agreements
T2 Biosystems, Inc. is taking a big step forward in the battle against sepsis with its latest distribution agreements. The company, which specializes in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, has announced exclusive deals to expand its commercial presence in the Netherlands, Belgium, Vietnam, and Switzerland.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
